Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Inhibition of altered peptide ligand-mediated antagonism of human GAD65-responsive CD4+ T cells by non-antagonizable T cells.

Gebe JA, Masewicz SA, Kochik SA, Reijonen H, Nepom GT.

Eur J Immunol. 2004 Dec;34(12):3337-45.

2.

A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.

Zavala-Ruiz Z, Strug I, Walker BD, Norris PJ, Stern LJ.

Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13279-84. Epub 2004 Aug 26.

3.
4.

Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.

Norris PJ, Moffett HF, Brander C, Allen TM, O'Sullivan KM, Cosimi LA, Kaufmann DE, Walker BD, Rosenberg ES.

AIDS Res Hum Retroviruses. 2004 Mar;20(3):315-25.

5.

A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspects.

Rudolph MG, Shen LQ, Lamontagne SA, Luz JG, Delaney JR, Ge Q, Cho BK, Palliser D, McKinley CA, Chen J, Wilson IA, Eisen HN.

J Immunol. 2004 Mar 1;172(5):2994-3002.

6.

Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity.

Kilgore NE, Carter JD, Lorenz U, Evavold BD.

J Immunol. 2003 May 15;170(10):4891-5.

7.
8.

TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways.

Stefanová I, Hemmer B, Vergelli M, Martin R, Biddison WE, Germain RN.

Nat Immunol. 2003 Mar;4(3):248-54. Epub 2003 Feb 10.

PMID:
12577055
9.

A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses.

Achour A, Michaëlsson J, Harris RA, Odeberg J, Grufman P, Sandberg JK, Levitsky V, Kärre K, Sandalova T, Schneider G.

Immunity. 2002 Dec;17(6):757-68.

11.

Labeling antigen-specific CD4(+) T cells with class II MHC oligomers.

Cameron TO, Norris PJ, Patel A, Moulon C, Rosenberg ES, Mellins ED, Wedderburn LR, Stern LJ.

J Immunol Methods. 2002 Oct 1;268(1):51-69. Review.

PMID:
12213343
12.

CD4(+) T helper cells and the role they play in viral control.

Norris PJ, Rosenberg ES.

J Mol Med (Berl). 2002 Jul;80(7):397-405. Epub 2002 Apr 12.

PMID:
12110945
14.

Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.

Norris PJ, Sumaroka M, Brander C, Moffett HF, Boswell SL, Nguyen T, Sykulev Y, Walker BD, Rosenberg ES.

J Virol. 2001 Oct;75(20):9771-9.

15.

Structural and functional consequences of altering a peptide MHC anchor residue.

Kersh GJ, Miley MJ, Nelson CA, Grakoui A, Horvath S, Donermeyer DL, Kappler J, Allen PM, Fremont DH.

J Immunol. 2001 Mar 1;166(5):3345-54.

16.
17.

Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction.

Chung CD, Patel VP, Moran M, Lewis LA, Miceli MC.

J Immunol. 2000 Oct 1;165(7):3722-9.

18.

TCR antagonist peptides induce formation of APC-T cell conjugates and activate a Rac signaling pathway.

Huang J, Sugie K, La Face DM, Altman A, Grey HM.

Eur J Immunol. 2000 Jan;30(1):50-8.

19.

Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation.

Kersh EN, Kersh GJ, Allen PM.

J Exp Med. 1999 Dec 6;190(11):1627-36.

20.

The crystal structure of a T cell receptor in complex with peptide and MHC class II.

Reinherz EL, Tan K, Tang L, Kern P, Liu J, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, Joachimiak A, Chang HC, Wagner G, Wang J.

Science. 1999 Dec 3;286(5446):1913-21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk